Michael Calloway

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. ncbi Development and validation of a subjective post sleep diary (SPSD) to assess sleep status in subjects with restless legs syndrome
    Michael Calloway
    GlaxoSmithKline, P O Box 13398, Research Triangle Park, NC 27709 3398, USA
    Sleep Med 12:704-10. 2011
  2. ncbi Validation of the post sleep questionnaire for assessing subjects with restless legs syndrome: results from two double-blind, multicenter, placebo-controlled clinical trials
    DANIEL M CANAFAX
    GlaxoSmithKline, Research Triangle Park, NC, USA
    BMC Neurol 11:48. 2011
  3. ncbi Health care resource utilization and costs associated with restless legs syndrome among managed care enrollees treated with dopamine agonists
    Juliana Meyers
    RTI Health Solutions, 200 Park Offices Drive, Research Triangle Park, NC 27709, USA
    Manag Care 21:44-51. 2012

Collaborators

Detail Information

Publications3

  1. ncbi Development and validation of a subjective post sleep diary (SPSD) to assess sleep status in subjects with restless legs syndrome
    Michael Calloway
    GlaxoSmithKline, P O Box 13398, Research Triangle Park, NC 27709 3398, USA
    Sleep Med 12:704-10. 2011
    ..To describe the development and psychometric properties of a daily subjective (patient-reported) sleep diary, the Subjective Post Sleep Diary (SPSD), that assesses sleep in relation to Restless Legs Syndrome (RLS)...
  2. ncbi Validation of the post sleep questionnaire for assessing subjects with restless legs syndrome: results from two double-blind, multicenter, placebo-controlled clinical trials
    DANIEL M CANAFAX
    GlaxoSmithKline, Research Triangle Park, NC, USA
    BMC Neurol 11:48. 2011
    ..The objective of this study was to validate a new measure, the Post Sleep Questionnaire (PSQ), to assess sleep dysfunction in subjects with moderate-to-severe RLS symptoms...
  3. ncbi Health care resource utilization and costs associated with restless legs syndrome among managed care enrollees treated with dopamine agonists
    Juliana Meyers
    RTI Health Solutions, 200 Park Offices Drive, Research Triangle Park, NC 27709, USA
    Manag Care 21:44-51. 2012
    ..This study assessed the direct economic burden of restless legs syndrome (RLS) among patients treated with dopamine agonists (DAs) using a large United States managed care database...